The Cigna Group (CI)
| Market Cap | 74.84B -17.0% |
| Revenue (ttm) | 277.89B +8.8% |
| Net Income | 6.29B +24.9% |
| EPS | 23.60 +31.2% |
| Shares Out | 264.53M |
| PE Ratio | 11.99 |
| Forward PE | 9.16 |
| Dividend | $6.24 (2.21%) |
| Ex-Dividend Date | Jun 4, 2026 |
| Volume | 1,520,035 |
| Open | 289.08 |
| Previous Close | 290.58 |
| Day's Range | 281.31 - 290.14 |
| 52-Week Range | 239.51 - 350.00 |
| Beta | 0.31 |
| Analysts | Strong Buy |
| Price Target | 348.40 (+23.15%) |
| Earnings Date | Apr 30, 2026 |
About CI
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty p... [Read more]
Financial Performance
In 2025, The Cigna Group's revenue was $274.90 billion, an increase of 11.24% compared to the previous year's $247.12 billion. Earnings were $5.96 billion, an increase of 73.47%.
Financial StatementsAnalyst Summary
According to 15 analysts, the average rating for CI stock is "Strong Buy." The 12-month stock price target is $348.4, which is an increase of 23.15% from the latest price.
News
Deal Dispatch: Sirius XM Mulls Purchase Of iHeartMedia, Uber Buys FlyTaxi, Wren Kitchens Bankruptcy
Cigna CEO Brian Evanko stated that the insurer is exploring strategic options for eviCore, which manages medical claims and reviews prior authorization requests. Cigna also plans to stop selling healt...
Cigna Raises Outlook, Flags Individual Exchange Exit And Strategic Review Of eviCore
The Cigna Group (NYSE:CI) shares are marginally down on Thursday as the company reported first-quarter results.
Cigna is becoming the second major insurer to exit from the ACA market as millions drop coverage with the expiration of federal subsidies.
Cigna Group will exit the Affordable Care Act market next year, citing an effort to focus on other lines of business.
Cigna Plans To Exit Obamacare In 2027 Affecting 369,000 With Coverage
The Cigna Group Thursday confirmed plans to exit the individual health insurance business also known as Obamacare next year, leaving about 369,00 health plan members in 11 states looking for new cover...
The Cigna Group Earnings Call Transcript: Q1 2026
Q1 2026 saw strong revenue and EPS growth, prompting a raised full-year outlook. Specialty and Care Services drove segment outperformance, while proactive portfolio actions included exiting the individual exchange business and reviewing EviCore. Leadership transition and continued AI-driven innovation position the company for sustained growth.
Cigna Revenue Rises on Evernorth Growth
Cigna Group logged higher profit and revenue in its latest quarter as its pharmacy-benefit business Evernorth continued to grow.
Cigna raises annual profit forecast after quarterly beat
Cigna slightly raised its annual adjusted profit forecast on Thursday after beating first-quarter earnings estimates, helped by strength in its health services unit and as medical costs came in lowe...
The Cigna Group Reports Strong First Quarter 2026 Results, Raises 2026 Outlook
Total revenues for the first quarter 2026 increased 5% to $68.5 billion Shareholders' net income for the first quarter 2026 was $1.7 billion, or $6.26 per share Adjusted income from operations1 for th...
Baron Capital Recognized with 2025 Cigna Healthy Workforce Designation™
NEW YORK--(BUSINESS WIRE)--Cigna Healthcare® has selected Baron Capital as a recipient of their 2025 gold level Healthy Workforce Designation for demonstrating a strong commitment to improving the hea...
The Cigna Group, Leading Health Plans Advance Work to Simplify Prior Authorization
BLOOMFIELD, Conn., April 24, 2026 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today joined leading health plans in a commitment to standardize electronic prior authorization su...
The Cigna Group Declares Quarterly Dividend
BLOOMFIELD, Conn., April 22, 2026 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.56 per share of its common stock, payable on June 18, 2026, ...
The Cigna Group Transcript: AGM 2026
The meeting reviewed strong 2025 financial results, major investments, and a CEO transition. All board nominees and management proposals were approved, while a shareholder proposal on written consent was rejected. Strategic initiatives focused on affordability and transparency.
The Cigna Group Foundation Invites Memphis-Area Nonprofits to Apply for $250,000 Grants to Improve Health Care Access
Nonprofits can apply through May 15 for two-year grants supporting community–led solutions to reduce barriers to health LEARN MORE AND APPLY HERE MEMPHIS, Tenn., April 16, 2026 /PRNewswire/ -- Buildin...
Cigna Healthcare Once Again Recognized for Industry Leading Digital Experience by JD Power
Customers rank myCigna highest for digital satisfaction as Cigna Healthcare continues to invest in AI-powered, personalized tools that make managing health care coverage simpler and more reliable BLO...
The Cigna Group's First Quarter 2026 Earnings Release Details
BLOOMFIELD, Conn., April 2, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its first quarter 2026 financial results on Thursday, April 30, 2026, and will host a conf...
The Cigna Group Foundation Supports More Than 8,000 Veterans Through Community-Led Housing Stability Programs
With grant funding, more than 20 nonprofit partners expanded access to stable housing and wraparound support services to support veteran communities in 10 states. Read the new Impact Report with outco...
Cigna Group CEO David Cordani on building the future of American health
Cigna Group CEO David Cordani reflects on the resilience, innovation and commitment to customers that have sustained the company for more than two centuries and continue to shape its future.
Cigna Stock Falls After CEO Retirement Announcement
The Cigna Group (NYSE: CI) shares are trading lower Tuesday after the company announced that David Cordani will retire as CEO.
Cigna's longtime CEO to step down as health insurers face growing scrutiny
Cigna names company veteran Brian Evanko as CEO to succeed David Cordani, who has been in charge for 27 years.
Cigna Names Brian Evanko CEO as David Cordani Retires
Cigna Group's longtime leader, David Cordani, is retiring as chief executive of the health insurer later this year and handing the reins to Brian Evanko.
Cigna CEO David Cordani To Retire And Be Replaced By Internal Choice
The Cigna Group Tuesday said long-time top executive David M. Cordani will retire as chief executive officer effective July 1, 2026, and be replaced by current president and chief operating officer Br...
Cigna names Brian Evanko as CEO
Cigna Group said on Tuesday David Cordani would retire as chief executive officer, effective July 1, and be succeeded by Brian Evanko, current president and chief operating officer.
The Cigna Group Announces President & COO Brian Evanko to Succeed David M. Cordani as Chief Executive Officer
Cordani to retire as chief executive officer on July 1, 2026, and will serve as executive chair of The Cigna Group Board of Directors Evanko elected to the company's Board of Directors Company reaffir...
Pacific Prime Takes the Top Individual Broker Award and the Top SME Broker at Cigna's Annual Broker Awards in Dubai
DUBAI, United Arab Emirates--(BUSINESS WIRE)--Pacific Prime, a leading international health insurance brokerage and employee benefits specialist, was awarded the Top Individual Broker award for six co...
The Cigna Group Transcript: TD Cowen 46th Annual Health Care Conference
Strong 2025 results set the stage for continued EPS growth and robust cash flow in 2026. Major investments support a new rebate-free PBM model, driving transparency and affordability, while specialty pharmacy expansion and biosimilar adoption fuel long-term growth.